Strata Skin Sciences, Inc. (NASDAQ:SSKN) has been assigned a $12.00 price target by stock analysts at HC Wainwright in a research note issued on Friday. The firm currently has a “buy” rating on the medical device company’s stock.

Several other brokerages have also commented on SSKN. ValuEngine raised Strata Skin Sciences from a “strong sell” rating to a “sell” rating in a research report on Friday, June 16th. Rodman & Renshaw raised their price objective on Strata Skin Sciences from $1.50 to $12.00 and gave the company a “buy” rating in a research report on Tuesday, May 16th.

Strata Skin Sciences (SSKN) traded down 11.28% on Friday, reaching $1.73. 30,685 shares of the company’s stock traded hands. The firm’s market capitalization is $4.29 million. The firm’s 50 day moving average price is $2.07 and its 200 day moving average price is $1.80. Strata Skin Sciences has a 52-week low of $1.65 and a 52-week high of $5.40.

Strata Skin Sciences (NASDAQ:SSKN) last announced its quarterly earnings data on Thursday, August 10th. The medical device company reported ($0.52) EPS for the quarter, beating the consensus estimate of ($0.71) by $0.19. The business had revenue of $8.70 million during the quarter, compared to analyst estimates of $7.98 million. Strata Skin Sciences had a negative return on equity of 39.57% and a negative net margin of 18.00%. On average, analysts predict that Strata Skin Sciences will post ($2.23) EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This story was posted by American Banking News and is owned by of American Banking News. If you are viewing this story on another publication, it was illegally stolen and republished in violation of U.S. & international trademark & copyright law. The correct version of this story can be viewed at https://www.americanbankingnews.com/2017/08/13/hc-wainwright-reiterates-12-00-price-target-for-strata-skin-sciences-inc-nasdaqsskn.html.

Strata Skin Sciences Company Profile

STRATA Skin Sciences, Inc, formerly MELA Sciences, Inc, is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Company has three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment and Dermatology Imaging.

Receive News & Ratings for Strata Skin Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Skin Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.